Sunil Healthcare has received an approval to add three new fully automatic state-of-art capsule manufacturing machines as the company is leveraging from the abundant Infrastructure available with it in regard to Land, and Building. The board of directors at their meeting held on November 10, 2014 has approved for the same. The company currently has 19 capsules making machines with approximately 7.7 billion Capsule manufacturing capacity.
Upon successful commissioning of these three machines, the capsule manufacturing capacity will be increased by 30% and total production capacity will be approximately 10 billion Capsules. The expansion strategy of the company has been planned keeping in mind its healthy order books from the Domestic and Export Customers.
Sunil Healthcare, having started its operations over three decades ago, is the second largest manufacturer of EHGC in India and enjoys immense credibility in various global markets.
| Company Name | CMP |
|---|---|
| SRF | 2709.30 |
| BASF India | 3492.00 |
| Tata Chemicals | 729.50 |
| Pidilite Inds. | 1579.50 |
| Deepak Nitrite | 1645.10 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: